GlaxoSmithkline

“Our Covid Vaccine Triggered Immune Response In Humans”: CureVac

CureVac’s experimental COVID-19 vaccine generated an immune response in humans, the German biotech firm said on Monday. “We are very encouraged by the interim Phase I data,” Chief Executive Officer…

View Post

Half a Million Sharks May Face Slaughter To Produce Global Covid-19 Vaccine

The world is grappling with the ongoing impacts of the Covid-19. The health-care system is working under constant pressure in this pandemic. There is no known cure for this virus…

View Post

Spotlight

Covid Shots: Will Rich Countries Monopolize Supply?

Will there be a Covid-19 vaccine, affordable and accessible to all? International agencies including WHO, and pharmaceutical companies as well as the developed countries have promised so. But the evidences…

View Post

US Sinks Another USD 2.1 Billion Into A Potential Vaccine

New Delhi: Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as governments buy up supplies…

View Post

Latest News

“Ache Din” For GlaxoSmithkline Consumer Healthcare Ltd

New Delhi: GlaxoSmithkline Consumer Healthcare Ltd on Thursday reported a 25.13 per cent jump in standalone net profit to Rs 276.63 crore for the quarter ending December 2019, driven by…

View Post

Menu

GlaxoSmithkline

“Our Covid Vaccine Triggered Immune Response In Humans”: CureVac

Half a Million Sharks May Face Slaughter To Produce Global Covid-19 Vaccine

Covid Shots: Will Rich Countries Monopolize Supply?

US Sinks Another USD 2.1 Billion Into A Potential Vaccine

“Ache Din” For GlaxoSmithkline Consumer Healthcare Ltd

Vinod Kambli Admitted To Hospital In Maharshtra, Condition Critical

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial